pharmaceutical-investing Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
pharmaceutical-investing Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial
pharmaceutical-investing Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
pharmaceutical-investing Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery
pharmaceutical-investing Corbus Pharmaceuticals Reports 2017 Financial Results and Provides Clinical Update
pharmaceutical-investing Calithera Biosciences Reports Fourth Quarter 2017 Financial Results and Recent Highlights
Moleculin Announces Collaboration with Emory University to Develop Novel Treatment of Pediatric Brain Cancer
BlackRock® Canada Announces Final January Cash Distributions for the iShares® Premium Money Market ETF
